Gene expression profiling in TPC1 cell line treated with the RTK inhibitor RPI-1
收藏NIAID Data Ecosystem2026-03-08 收录
官方服务：
资源简介：
We treated the papillary thyroid carcinoma-derived cell line TPC1 with the RTK inhibitor RPI-1 to obtain a thyroid carcinoma cell model. The RET tyrosine kinase is a target of the inhibitor. Gene expression changes were evaluated comparing cells treated with the inhibitor for 24 hours versus cells treated with DMSO for 24 hours. Biological triplicates for RPI-1 and DMSO treated cells were generated by independent treatments and total RNA extractions.
创建时间：
2014-07-10
